/wp-content/uploads/2024/10/CompanyName-300x300.png
0
0
gatekeeper
/wp-content/uploads/2024/10/CompanyName-300x300.png
gatekeeper2025-04-23 14:39:462025-04-23 14:39:47Using an integrated immunopeptidomic and HLA modeling system to develop a novel influenza A T-cell priming vaccine
/wp-content/uploads/2024/10/CompanyName-300x300.png
0
0
gatekeeper
/wp-content/uploads/2024/10/CompanyName-300x300.png
gatekeeper2025-02-13 14:01:392025-02-17 08:33:47Using targeted mass spectrometry to characterize the mechanism of action for a novel T cell-priming vaccine delivery system
/wp-content/uploads/2024/10/CompanyName-300x300.png
0
0
gatekeeper
/wp-content/uploads/2024/10/CompanyName-300x300.png
gatekeeper2025-02-13 13:46:152025-02-13 14:09:54New approach: MHC class I peptide libraries for the treatment of viral and bacterial infectious diseases by innovative multi-epitope T cell adaptive vaccines
/wp-content/uploads/2024/10/CompanyName-300x300.png
0
0
gatekeeper
/wp-content/uploads/2024/10/CompanyName-300x300.png
gatekeeper2025-02-13 13:45:282025-03-19 10:02:38Rapid Emergex Antigen Deployment Initiative (READI): a synthetic T cell vaccine technology platform pairing a gold nanoparticle delivery system with select targets from a ligandome of prescreened pathogen derived, naturally processed & presented MHC-I peptides to provide rapid response solutions to combat and broadly protect against biothreat pathogens
/wp-content/uploads/2024/10/CompanyName-300x300.png
0
0
gatekeeper
/wp-content/uploads/2024/10/CompanyName-300x300.png
gatekeeper2025-02-13 13:44:412025-03-19 10:01:34Characterization of a T cell adaptive vaccine platform to prime a broad and durable immunogenic response against Dengue virus infection
/wp-content/uploads/2024/10/CompanyName-300x300.png
0
0
gatekeeper
/wp-content/uploads/2024/10/CompanyName-300x300.png
gatekeeper2025-02-13 13:42:432025-02-13 14:06:26Novel gene identification in the influenza virus infection model using multi-omics approach, reveals potential CD8+ T-cell adaptive vaccine candidates
/wp-content/uploads/2024/10/CompanyName-300x300.png
0
0
gatekeeper
/wp-content/uploads/2024/10/CompanyName-300x300.png
gatekeeper2025-02-13 13:41:522025-02-17 08:35:11A novel immunoproteomic approach to MHC class I-restricted peptide discovery for influenza CD8+ T cell adaptive vaccine development
/wp-content/uploads/2024/10/CompanyName-300x300.png
0
0
gatekeeper
/wp-content/uploads/2024/10/CompanyName-300x300.png
gatekeeper2025-02-13 13:41:032025-02-18 09:48:29Emergex’s Next Generation Vaccines: Naturally processed & presented MHC class I ligandome libraries for the development of T cell priming immune set-point vaccines against infectious pathogens
/wp-content/uploads/2024/10/CompanyName-300x300.png
0
0
gatekeeper
/wp-content/uploads/2024/10/CompanyName-300x300.png
gatekeeper2025-02-13 13:39:392025-02-13 14:03:16Label-free quantitative proteomics characterizes immunopathogenesis of Chikungunya virus infection in hepatocellular carcinoma cells
/wp-content/uploads/2024/10/CompanyName-300x300.png
0
0
gatekeeper
/wp-content/uploads/2024/10/CompanyName-300x300.png
gatekeeper2025-02-13 13:31:272025-02-13 14:00:33Novel immunopeptidomic discovery of MHC class I restricted SARS-CoV-2 peptides for next generation COVID19 T cell priming vaccines
Scroll to top
